Mereo BioPharma Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	45	433	254	73	128	177
Market Cap Growth	-87.30%	70.57%	249.41%	-43.41%	-27.46%	264.76%
Enterprise Value	10	374	221	14	37	162
Last Close Price	0.28	2.76	1.85	0.62	1.20	-
PE Ratio	-	-	-	-	10.09	-
PS Ratio	122.07	-	32.34	-	3.52	-
PB Ratio	1.31	8.89	6.40	1.70	1.46	-11.82
P/TBV Ratio	1.33	8.99	6.54	1.70	2.02	-
EV/Sales Ratio	27.11	-	28.17	-	1.02	-
Debt / Equity Ratio	0.01	0.11	0.12	0.30	0.19	-1.20
Net Debt / Equity Ratio	-1.04	-1.04	-1.02	-1.03	-0.88	0.37
Net Debt / EBITDA Ratio	1.07	1.40	1.94	1.01	3.72	0.15
Net Debt / FCF Ratio	1.48	1.93	2.44	1.08	13.43	0.20
Asset Turnover	0.01	-	0.14	-	0.39	-
Quick Ratio	8.35	5.24	6.38	2.89	7.66	3.23
Current Ratio	8.71	5.40	6.72	3.09	7.92	3.47
Return on Equity (ROE)	-69.79%	-77.58%	-57.81%	-53.63%	34.85%	-1294.27%
Return on Assets (ROA)	-39.81%	-39.99%	-23.57%	-28.67%	-13.82%	-31.43%
Return on Invested Capital (ROIC)	-	-	-	-825.95%	-	-220.12%
Return on Capital Employed (ROCE)	-95.30%	-73.10%	-47.60%	-99.40%	-18.40%	-69.10%
Earnings Yield	-68.11%	-7.98%	-9.11%	-48.22%	9.91%	-92.45%
FCF Yield	-53.62%	-6.06%	-6.54%	-55.78%	-4.50%	-16.02%
Buyback Yield / Dilution	-9.71%	-12.16%	-9.33%	-8.63%	-63.82%	-279.04%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.